Cost-effectiveness of massively parallel sequencing for diagnosis of paediatric muscle diseases
Deborah Schofield, Khurshid Alam, Lyndal Douglas, Rupendra Shrestha, Daniel G MacArthur, Mark Davis, Nigel G Laing, Nigel F Clarke, Joshua Burns, Sandra T Cooper, Kathryn N North, Sarah A Sandaradura, Gina L O'Grady
npj Genomic Medicine | NATURE PUBLISHING GROUP | Published : 2017
Awarded by National Health and Medical Research Council of Australia
Awarded by NHMRC-European Union
Awarded by NIH National Human Genome Research Institute
This study was supported by the National Health and Medical Research Council of Australia (1022707, 1031893, N.F.C,N.G.L., K.N.N, J.B.; APP1002147, N.G.L.; GNT1113531, K.N., N.G.L., S.T.C., D.S.; 1056285, G.L.O; 1075451, S.A.S; 1048816 S.T.C; 1080587 N.G.L., S.T.C., D.G.M., N.F.C., K.N.N.), NHMRC-European Union Collaborative Research Grant Scheme (1055131, K.N., J.B) and the Victorian Government's Operational Infrastructure Support Program. G.L.O. received funding from Muscular Dystrophy NSW and the Royal Australasian College of Physicians. Exome sequencing was supported by grants from the NIH National Human Genome Research Institute (Medical Sequencing Program grant U54 HG003067 to the Broad Institute principal investigator).